News

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

Amphastar raised to Buy at Needham on iron sucrose injection approval

Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
TipRanks on MSN20h

Amphastar announced FDA approval of iron sucrose injection

Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...
TipRanks on MSN20h

Needham upgrades Amphastar on valuation post AMP-002 approval

Needham upgraded Amphastar (AMPH) (APMH) to Buy from Hold with a $36 price target. The company’s AMP-002 is an iron sucrose injection product that ...

Amphastar boosts pipeline with exclusive licensing deal from Nanjing Anji

Amphastar Pharmaceuticals (AMPH) has entered into an exclusive license agreement with Nanjing Anji Biotechnology for the development, manufacturing, use, and commercialization of three proprietary ...

Cava's shares crater after first annual sales growth target cut since IPO

(Reuters) -Shares of Cava dropped 21% in extended trading on Tuesday, after the Mediterranean restaurant chain lowered its annual same-store sales growth target for the first time since it listed on ...